Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Riluzole.
Cerebral venous sinus thrombosis in the patient with multiple sclerosis associated with congenital antithrombin deficiency.
Comprehension and Data-Sharing Behavior of Direct-To-Consumer Genetic Test Customers.
Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions.
Incidence and prevalence of multiple sclerosis in southeastern Iran.
Abrogation of β-Catenin Signaling in Oligodendrocyte Precursor Cells Reduces Glial Scarring and Promotes Axon Regeneration after CNS Injury.
The impact of walking speed on the effects of functional electrical stimulation for foot drop in people with multiple sclerosis.
Relapsing-remitting multiple sclerosis and chronic idiopathic neutropenia: a challenging combination.
Immunomodulation of fucosyl-lactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects.
Can a Low-Cost Webcam be Used for a Remote Neurological Exam?
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis (Abili-T)
[Transorbital echography for assessment of optical nerve atrophy in demyelinating diseases: a pilot study].
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.
Vitamin D in MS: A vitamin for 4 seasons.
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and upregulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study.
Anesthetic management of a parturient with neuromyelitis optica.
Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier.
Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease.
Does multiple sclerosis affect glucose tolerance?
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.
[Marihuana and cannobinoids as medicaments].
Natalizumab adverse events are rare in patients with multiple sclerosis.
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology.
Pages
« first
‹ previous
…
226
227
228
229
230
231
232
233
234
…
next ›
last »